SENSIENT TECHNOLOGIES CORP annual report, FY2020

Sensient Technologies Corporation — FY2020 Form 10-K

Reporting period: Fiscal year ended December 31, 2020. This is an annual report, not a standalone fourth-quarter filing; quarterly figures below are included for context. Sensient makes specialty colors, flavors, extracts, and ingredients for food, beverage, pharmaceutical, cosmetic, and other markets.

Financial performance

MetricFY2020FY2019Change / context
Revenue$1,332.0 million$1,322.9 millionUp 0.7% reported; adjusted revenue, excluding product lines divested or to be divested, rose 3.3% to $1,218.4 million.
Gross profit / margin$423.7 million / 31.8%$414.9 million / 31.4%Margin increased 0.4 percentage points.
Operating income / margin$152.7 million / 11.5%$121.1 million / 9.2%GAAP operating income rose 26.0%; adjusted operating income declined 0.9% to $163.6 million.
Net earnings$109.5 million$82.0 millionUp 33.4%.
Diluted EPS$2.59$1.94Adjusted diluted EPS was $2.79 versus $2.92, down 4.5%.
Operating cash flow$218.8 million$177.2 millionIncrease primarily reflected favorable working-capital changes.
Capital expenditures$52.2 million$39.1 millionUp $13.1 million.
Debt and liquidityTotal debt approximately $527.3 million; cash $24.8 millionTotal debt approximately $619.1 million; cash $21.2 millionDebt declined; $329.0 million was available under the revolving facility and $45.8 million under other bank lines.
Dividends$1.56 per share; $66.1 million paid$1.47 per share; $62.2 million paidQuarterly dividend declared at $0.39 per share, payable March 1, 2021.

Fourth-quarter context: Revenue was $334.7 million versus $318.6 million in Q4 2019; net earnings were $25.2 million versus a $17.0 million loss, and diluted EPS was $0.59 versus a $0.40 loss per share.

Material changes and segment results

  • Flavors & Extracts revenue increased about 6% to $742.0 million and segment operating income rose about 21% to $91.0 million. Growth in flavors and natural ingredients more than offset weaker yogurt fruit preparations and fragrances.
  • Color revenue fell about 6% to $501.0 million and segment operating income fell about 5% to $96.0 million. Lower personal-care demand, particularly makeup, and the inks divestiture weighed on results; Food & Pharmaceutical Colors grew.
  • Asia Pacific revenue rose about 3% to $121.2 million and segment operating income increased about 14% to $22.1 million, reflecting higher volumes and lower raw-material costs.
  • Reported earnings benefited from substantially lower divestiture-related charges than in 2019. 2020 included $18.5 million of divestiture, operational-improvement, and one-time COVID-19 employee-payment costs ($14.4 million after tax); 2019 included $45.9 million of divestiture-related costs ($43.2 million after tax).
  • Cash from operations increased, while the company used $184.2 million in financing activities, including $117.7 million of net debt reduction and $66.1 million in dividends.

Outlook, commentary, risks, and unusual items

  • Management said COVID-19’s net effect on 2020 results was negative: some product lines benefited, but those gains were outweighed by reduced demand for cosmetics and certain food products. Facilities generally remained open, and management described supply operations as continuing through the pandemic.
  • The company expected to complete the sale of the fragrances product line, excluding essential oils, in the first half of 2021. It estimated 2021 divestiture costs of $10–$14 million, including a projected non-cash $8–$10 million foreign-currency reclassification charge.
  • A 2020 operational improvement plan consolidates a New Jersey cosmetics facility into Missouri, centralizes some European support functions, and reduces certain Asia Pacific administrative positions. Expected total 2020–2021 costs were $5–$7 million.
  • Management estimated a 2021 effective tax rate of 24%–25%, before divestiture costs and discrete tax items. The filing does not provide broader revenue or earnings guidance.
  • COVID-19-related uncertainties include potential facility closures, workforce impacts, supply and freight disruption, customer demand changes, and delayed product launches. Other cited risks include competition, raw-material and energy costs, foreign exchange, Brexit and trade restrictions, customer concentration in some product lines, and cybersecurity.
  • Environmental sampling at the Granada, Spain property identified soil and groundwater contaminants. The company accrued an estimated $0.8 million for remediation, but actual costs could exceed the estimate. The filing also describes California wage-related class and representative actions; management intends to defend them, and states that other ordinary-course matters are not expected to have a material adverse effect based on currently known facts.
  • Approximately 20% of debt referenced LIBOR at year-end 2020; the company cited potential cost uncertainty as LIBOR transitions to replacement rates. Loan covenants were met, with debt-to-EBITDA of 2.40 against a maximum of 3.50 and interest coverage of 6.61 against a minimum of 2.00.

Important facts for investors to verify

  • Reconcile GAAP earnings improvement with the decline in adjusted EPS and review the company’s non-GAAP definitions and exclusions.
  • Track the fragrances sale, its expected 2021 costs, and whether remaining businesses sustain adjusted revenue and operating performance after divestitures.
  • Assess continued COVID-19 effects on personal care, food-service-related demand, customer launches, suppliers, and transportation.
  • Monitor debt reduction, revolving-credit availability, upcoming maturities, and the LIBOR transition; confirm covenant headroom.
  • Review the Granada remediation estimate and developments in the disclosed employment litigation.

The independent auditor issued an unqualified opinion on the financial statements and internal controls. All amounts are as reported in the filing; adjusted measures are non-GAAP and are supplemental to GAAP results.